抗凝药使用与初发自发性脑出血出血部位及病因的关联
该横断面分析纳入2008至2023年波士顿某三级医院1104例初发自发性脑出血患者,抗凝相关脑出血268例(24.3%)。抗凝相关脑出血与脑叶出血部位无关(OR 0.80,95%CI 0.61-1.05),但与可能脑淀粉样血管病几率降低相关(MRI:OR 0.44,95%CI 0.25-0.75)。作者认为高血压微血管病可能比脑淀粉样血管病更易导致抗凝相关脑出血,并强调抗凝使用者血压控制的重要性,结论需在其他队列中重复验证。
要点
- 抗凝相关脑出血与脑叶出血部位无显著关联(OR 0.80,95%CI 0.61-1.05)。
- 抗凝相关脑出血患者MRI可能脑淀粉样血管病几率降低(OR 0.44,95%CI 0.25-0.75)。
- 维生素K拮抗剂与直接口服抗凝药使用者脑叶出血和可能脑淀粉样血管病比例无差异。
核心结论
- 抗凝相关脑出血与脑叶出血部位无关,但与可能脑淀粉样血管病几率降低相关。
- 作者认为高血压微血管病可能比脑淀粉样血管病更易导致初发抗凝相关脑出血。
- 作者强调抗凝使用者血压控制的重要性,并指出这些发现需在其他队列中重复验证。
研究设计与样本
- 横断面分析,纳入2008至2023年波士顿某三级医院收治的初发自发性脑出血患者。
- 共纳入1104例患者,平均(标准差)年龄73(12)岁,女性499例(45.0%)。
- 采用单变量和多变量逻辑回归分析抗凝使用与脑叶出血部位及可能脑淀粉样血管病的关联。
- 可能脑淀粉样血管病依据磁共振成像(MRI)的Boston标准2.0或未行MRI时依据计算机断层扫描的简化Edinburgh标准判定。
主要发现
- 1104例中268例(24.3%)为抗凝相关脑出血,其中维生素K拮抗剂148例(55.2%),直接口服抗凝药107例(39.9%)。
- 695例(63.0%)患者接受了脑MRI检查。
- 抗凝相关脑出血组与非抗凝相关脑出血组脑叶出血比例无差异(121/268 [45.1%] vs 424/836 [50.7%];OR 0.80,95%CI 0.61-1.05;P=0.113)。
- 抗凝相关脑出血组MRI可能脑淀粉样血管病比例低于非抗凝相关脑出血组(17/146 [11.6%] vs 127/549 [23.1%];OR 0.44,95%CI 0.25-0.75;P=0.002)。
- 抗凝相关脑出血组MRI或未行MRI时CT可能脑淀粉样血管病比例低于非抗凝相关脑出血组(27/268 [10.0%] vs 200/836 [23.9%];OR 0.36,95%CI 0.23-0.55;P<0.001)。
关键数值与推荐
- 抗凝相关脑出血组与非抗凝相关脑出血组脑叶出血比例:121/268(45.1%)vs 424/836(50.7%),OR 0.80(95%CI 0.61-1.05),P=0.113。
- 抗凝相关脑出血组与非抗凝相关脑出血组MRI可能脑淀粉样血管病比例:17/146(11.6%)vs 127/549(23.1%),OR 0.44(95%CI 0.25-0.75),P=0.002。
- 抗凝相关脑出血组与非抗凝相关脑出血组MRI或CT可能脑淀粉样血管病比例:27/268(10.0%)vs 200/836(23.9%),OR 0.36(95%CI 0.23-0.55),P<0.001。
- 抗凝相关脑出血患者中维生素K拮抗剂组与直接口服抗凝药组脑叶出血比例:63/148(42.6%)vs 46/107(43.0%),OR 1.02(95%CI 0.62-1.68),P=0.946。
- 抗凝相关脑出血患者中维生素K拮抗剂组与直接口服抗凝药组MRI可能脑淀粉样血管病比例:10/72(13.9%)vs 7/69(10.1%),OR 0.70(95%CI 0.25-1.96),P=0.495。
临床怎么用
- 作者认为高血压微血管病可能比脑淀粉样血管病更易导致初发抗凝相关脑出血,并强调抗凝使用者血压控制的重要性。
- 作者指出这些发现需在其他队列中重复验证。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It is unknown whether hypertensive microangiopathy or cerebral amyloid angiopathy (CAA) predisposes more to anticoagulant-associated intracerebral hemorrhage (AA-ICH). The purpose of our study was to determine whether AA-ICH is associated with lobar location and probable CAA. METHODS: This was a cross-sectional analysis of patients with first-ever spontaneous ICH admitted to a tertiary hospital in Boston, between 2008 and 2023. Univariable and multivariable logistic regression were used to investigate the association between anticoagulation use and both lobar hemorrhage location and probable CAA on magnetic resonance imaging (MRI) by Boston Criteria 2.0 or computed tomography by Simplified Edinburgh Criteria. RESULTS: A total of 1104 patients (mean [SD] age, 73 [12]; 499 females [45.0%]) were included. Of the 1104 patients, 268 (24.3%) had AA-ICH: 148 (55.2%) with vitamin K antagonists and 107 (39.9%) with direct oral anticoagulants. Brain MRI was performed in 695 (63.0%) patients. The proportion of patients with lobar hemorrhage was not different between those with and without AA-ICH (121/268 [45.1%] versus 424/836 [50.7%]; odds ratio [OR], 0.80 [95% CI, 0.61-1.05]; P=0.113). Patients with AA-ICH were less likely to have probable CAA on MRI (17/146 [11.6%] versus 127/549 [23.1%]; OR, 0.44 [95% CI, 0.25-0.75]; P=0.002) and probable CAA on MRI or computed tomography if MRI not performed (27/268 [10.0%] versus 200/836 [23.9%]; OR, 0.36 [95% CI, 0.23-0.55]; P<0.001). Among patients with AA-ICH, there were no differences in the proportion with lobar hemorrhage (63/148 [42.6%] versus 46/107 [43.0%]; OR, 1.02 [95% CI, 0.62-1.68]; P=0.946) or probable CAA on MRI (10/72 [13.9%] versus 7/69 [10.1%]; OR, 0.70 [95% CI, 0.25-1.96]; P=0.495) between vitamin K antagonists and direct oral anticoagulant users. CONCLUSIONS: AA-ICH was not associated with lobar hemorrhage location but was associated with reduced odds of probable CAA. These results suggest that hypertensive microangiopathy may predispose more toward incident AA-ICH than CAA and emphasize the importance of blood pressure control among anticoagulant users. These findings require replication in additional cohorts.
引用
- Wilson M, Incontri D, Vu S, et al. Association of Anticoagulant Use With Hemorrhage Location and Etiology in Incident Spontaneous Intracerebral Hemorrhage. Stroke. 2024. PMID: 39355909. doi:10.1161/STROKEAHA.124.048243
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。